Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BCYC will decline by -4.68% over the next 2 Weeks and hit $6.48 by Tuesday, January 13, 2026. In that time frame, BCYC's share price is expected to range between $6.19 and $6.76.
BearishAverageBullishBCYC shares rose +4.12% in Wednesday, December 31, 2025's trading session, rising from a previous close of $6.80 to move at $7.08. The stock demonstrated notable intraday movement (see BCYC's key stats for a full breakdown), fluctuating between $6.73 and $7.11, a +5.65% trading range. While recent weeks have seen some volatility, BCYC has managed to secure a -3.15% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 232.46K shares changing hands, 48.71K more than the previous session. This amounted to $1.65M in total market activity.
Will BCYC Continue Its Downward Trend?
According to analyst ratings and projections for BCYC, Bicycle Therapeutics plc shares are anticipated to decrease by -4.67%, potentially reaching $6.76 per share by January 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for BCYC. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the BCYC stock forecast, now is not the best time to buy BCYC stock because its current trading price is +9.23% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BCYC covering social and institutional perspectives.
BCYC Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BCYC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 49.87% to 52.92%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 48.24%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.40%, maintains a neutral outlook for the long term. Insights into BCYC's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Bicycle Therapeutics plc Monthly Forecast 2026
January 2026
According to our latest forecast models, Bicycle Therapeutics plc (BCYC) is positioned to show a strong performance in January 2026. The price is predicted to move between $7.76 and $11.35, settling at an average of $9.64. This could translate to a +36.16% gain.
February 2026
Based on current market signals, Bicycle Therapeutics plc is projected to trend february 2026. We forecast a trading range from $7.06 to $8.41, with a likely average price of $7.75. Investors could expect a potential return of +9.46%.
March 2026
Our predictive algorithms indicate Bicycle Therapeutics plc stock may see a shift in March 2026. The expected range spans $6.18–$8.12, with an average target of $7.37. This represents a positive outlook and a possible gain of +4.10%.
April 2026
Analyzing established trends, Bicycle Therapeutics plc looks set to move in April 2026. Projections place the stock between $4.03 and $7.62, averaging around $5.98. This suggests a -15.54% loss from current levels.
May 2026
Market indicators suggest Bicycle Therapeutics plc could experience notable changes during May 2026. Prices could fluctuate within $3.45 to $6.28, with a midpoint forecast of $6.07. The stock might deliver a -14.27% loss.
June 2026
Forecasting for June 2026, models estimate that Bicycle Therapeutics plc may undergo key fluctuations. If trends hold, the stock might trade between $1.30 and $5.85, averaging $5.60. This signals a cautious trajectory with potential returns around -20.90%.
July 2026
According to our latest forecast models, Bicycle Therapeutics plc (BCYC) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $4.34, settling at an average of $4.90. This could translate to a -30.79% loss.
August 2026
Based on current market signals, Bicycle Therapeutics plc is projected to trend august 2026. We forecast a trading range from $0.00 to $4.05, with a likely average price of $5.20. Investors could expect a potential return of -26.55%.
September 2026
Our predictive algorithms indicate Bicycle Therapeutics plc stock may see a shift in September 2026. The expected range spans $0.00–$3.71, with an average target of $4.96. This represents a cautious outlook and a possible loss of -29.94%.
October 2026
Analyzing established trends, Bicycle Therapeutics plc looks set to move in October 2026. Projections place the stock between $0.00 and $2.80, averaging around $5.19. This suggests a -26.69% loss from current levels.
November 2026
Market indicators suggest Bicycle Therapeutics plc could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $1.33, with a midpoint forecast of $4.58. The stock might deliver a -35.31% loss.
December 2026
Forecasting for December 2026, models estimate that Bicycle Therapeutics plc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.54, averaging $4.39. This signals a cautious trajectory with potential returns around -37.99%.
BCYC's history of dividends and stock splits also plays a role in long-term investor confidence.